<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab1">
 <label>Table 1</label>
 <caption>
  <p>Summary of Parkinson’s genes first identified in familial and early-onset cases of PD and risk factors.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Gene (Chromosomal position)</th>
    <th>Gene product</th>
    <th>Function</th>
    <th>Inheritance</th>
    <th>Mutations studied in iPSC studies</th>
    <th>Reference (iPSC studies)</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>SNCA (4q21)</td>
    <td>a-synuclein</td>
    <td>Suppression of apoptosis, chaperone activity, antioxidation, neuronal differentiation, regulation of DA biosynthesis</td>
    <td>AD</td>
    <td>A53T; E46K; duplication; triplication</td>
    <td>
     <xref ref-type="bibr" rid="CR28">28</xref>,
     <xref ref-type="bibr" rid="CR30">30</xref>,
     <xref ref-type="bibr" rid="CR33">33</xref>–
     <xref ref-type="bibr" rid="CR35">35</xref>,
     <xref ref-type="bibr" rid="CR41">41</xref>,
     <xref ref-type="bibr" rid="CR42">42</xref>,
     <xref ref-type="bibr" rid="CR49">49</xref>,
     <xref ref-type="bibr" rid="CR55">55</xref>,
     <xref ref-type="bibr" rid="CR60">60</xref>,
     <xref ref-type="bibr" rid="CR66">66</xref>,
     <xref ref-type="bibr" rid="CR73">73</xref>,
     <xref ref-type="bibr" rid="CR80">80</xref>,
     <xref ref-type="bibr" rid="CR83">83</xref>,
     <xref ref-type="bibr" rid="CR84">84</xref>,
     <xref ref-type="bibr" rid="CR89">89</xref>,
     <xref ref-type="bibr" rid="CR90">90</xref>,
    </td>
   </tr>
   <tr>
    <td>PRKN(6q25.2-q27)</td>
    <td>Parkin</td>
    <td>Mitochondrial quality control</td>
    <td>AR</td>
    <td>V324A; T240R; R275W; R42P; −1 bp del 255A; Exon 3–4 del; Exon 2 del; Exon 3/5 del; Exon 6/7 del; Exon 2/4 del; Exon 5/6 del; Exon5 del; Exon 3 del</td>
    <td>
     <xref ref-type="bibr" rid="CR24">24</xref>,
     <xref ref-type="bibr" rid="CR29">29</xref>,
     <xref ref-type="bibr" rid="CR31">31</xref>,
     <xref ref-type="bibr" rid="CR39">39</xref>,
     <xref ref-type="bibr" rid="CR40">40</xref>,
     <xref ref-type="bibr" rid="CR42">42</xref>,
     <xref ref-type="bibr" rid="CR54">54</xref>,
     <xref ref-type="bibr" rid="CR64">64</xref>,
     <xref ref-type="bibr" rid="CR68">68</xref>,
     <xref ref-type="bibr" rid="CR71">71</xref>,
     <xref ref-type="bibr" rid="CR74">74</xref>,
     <xref ref-type="bibr" rid="CR76">76</xref>,
     <xref ref-type="bibr" rid="CR77">77</xref>,
     <xref ref-type="bibr" rid="CR84">84</xref>,
     <xref ref-type="bibr" rid="CR88">88</xref>,
     <xref ref-type="bibr" rid="CR91">91</xref>,
    </td>
   </tr>
   <tr>
    <td>PINK1 (1p35-p36)</td>
    <td>PTEN-induced kinase 1</td>
    <td>Mitochondrial quality control</td>
    <td>AR</td>
    <td>G309D; V170G; Q456X</td>
    <td>
     <xref ref-type="bibr" rid="CR31">31</xref>,
     <xref ref-type="bibr" rid="CR32">32</xref>,
     <xref ref-type="bibr" rid="CR52">52</xref>,
     <xref ref-type="bibr" rid="CR62">62</xref>,
     <xref ref-type="bibr" rid="CR70">70</xref>,
     <xref ref-type="bibr" rid="CR71">71</xref>,
     <xref ref-type="bibr" rid="CR85">85</xref>,
    </td>
   </tr>
   <tr>
    <td>DJ-1 (1p36)</td>
    <td>DJ-1</td>
    <td>Protection against oxidative stress</td>
    <td>AR</td>
    <td>E46D</td>
    <td>
     <xref ref-type="bibr" rid="CR27">27</xref>
    </td>
   </tr>
   <tr>
    <td>LRRK2 (12q12)</td>
    <td>Leucine rich repeat kinase 2</td>
    <td>Membrane trafficking, mitochondrial membrane maintenance</td>
    <td>AD</td>
    <td>G2019S; R1441C; R1441G; I2020T</td>
    <td>
     <xref ref-type="bibr" rid="CR26">26</xref>,
     <xref ref-type="bibr" rid="CR32">32</xref>,
     <xref ref-type="bibr" rid="CR37">37</xref>,
     <xref ref-type="bibr" rid="CR38">38</xref>,
     <xref ref-type="bibr" rid="CR42">42</xref>–
     <xref ref-type="bibr" rid="CR44">44</xref>,
     <xref ref-type="bibr" rid="CR46">46</xref>–
     <xref ref-type="bibr" rid="CR48">48</xref>,
     <xref ref-type="bibr" rid="CR50">50</xref>,
     <xref ref-type="bibr" rid="CR51">51</xref>,
     <xref ref-type="bibr" rid="CR53">53</xref>,
     <xref ref-type="bibr" rid="CR56">56</xref>,
     <xref ref-type="bibr" rid="CR57">57</xref>,
     <xref ref-type="bibr" rid="CR61">61</xref>,
     <xref ref-type="bibr" rid="CR65">65</xref>,
     <xref ref-type="bibr" rid="CR78">78</xref>,
     <xref ref-type="bibr" rid="CR79">79</xref>,
     <xref ref-type="bibr" rid="CR82">82</xref>,
     <xref ref-type="bibr" rid="CR84">84</xref>,
     <xref ref-type="bibr" rid="CR86">86</xref>,
     <xref ref-type="bibr" rid="CR87">87</xref>,
    </td>
   </tr>
   <tr>
    <td>ATP13A2 (1p36)</td>
    <td>Cation-transporting ATPase 13A2</td>
    <td>Cation homeostasis, lysosomal function</td>
    <td>AR</td>
    <td>N/A</td>
    <td>N/A</td>
   </tr>
   <tr>
    <td>VPS35 (16q11.2)</td>
    <td>Vacuolar protein sorting 35</td>
    <td>Recycling of membrane proteins between endosomes and the trans-Golgi network</td>
    <td>AD</td>
    <td>N/A</td>
    <td>N/A</td>
   </tr>
   <tr>
    <td>DNAJC6 (1p31.3)</td>
    <td>DNAJ subfamily C member 6</td>
    <td>Clathrin mediated endocytosis</td>
    <td>AR</td>
    <td>N/A</td>
    <td>N/A</td>
   </tr>
   <tr>
    <td>FBXO7 (22q12–q13)</td>
    <td>F-box protein 7</td>
    <td>Phosphorylation-dependent ubiquitination</td>
    <td>AR</td>
    <td>N/A</td>
    <td>N/A</td>
   </tr>
   <tr>
    <td>SYNJ1 (21q22.11)</td>
    <td>Synaptojanin-1</td>
    <td>Regulation of synaptic vesicle endocytosis</td>
    <td>AR</td>
    <td>N/A</td>
    <td>N/A</td>
   </tr>
   <tr>
    <td>PLA2G6 (22q12–q13)</td>
    <td>Phospholipase A2, group 6</td>
    <td>Phospholipid remodeling, mitochondrial function</td>
    <td>AR</td>
    <td>N/A</td>
    <td>N/A</td>
   </tr>
   <tr>
    <td>CHCHD2 (7p11.2)</td>
    <td>Coiled-coil-helix-coiled-coil-helix domain 2</td>
    <td>Regulation of mitochondrial metabolism under oxygen stress</td>
    <td>AD</td>
    <td>N/A</td>
    <td>N/A</td>
   </tr>
   <tr>
    <td>GIGYF2 (2q36–q37)</td>
    <td>GRB10 interacting GYF protein 2</td>
    <td>Negative regulation of cell growth</td>
    <td>AD</td>
    <td>N/A</td>
    <td>N/A</td>
   </tr>
   <tr>
    <td>Omi/HTRA2 (2p13)</td>
    <td>High-temperature requirement A2</td>
    <td>Neuroprotection</td>
    <td>AR</td>
    <td>N/A</td>
    <td>N/A</td>
   </tr>
   <tr>
    <td>VPS13C (15q22.2)</td>
    <td>Vacuolar protein sorting 13C</td>
    <td>Maintenance of mitochondrial function</td>
    <td>AR</td>
    <td>N/A</td>
    <td>N/A</td>
   </tr>
   <tr>
    <td>EIF4G1 (3q27.1)</td>
    <td>Eukaryotic translation initiation factor 4 gamma 1</td>
    <td>Regulation of mRNAs translation</td>
    <td>AD</td>
    <td>N/A</td>
    <td>N/A</td>
   </tr>
   <tr>
    <td>UCHL1 (4p13)</td>
    <td>Ubiquitin C-terminal hydrolase L1</td>
    <td>Ubiquitin–proteasome system and neuronal survival</td>
    <td>AD</td>
    <td>N/A</td>
    <td>N/A</td>
   </tr>
   <tr>
    <td>GBA (1q21)</td>
    <td>Glucosylceramidase Beta</td>
    <td>Lysosomal function</td>
    <td>RF</td>
    <td>N370S; L444P; RecNil</td>
    <td>
     <xref ref-type="bibr" rid="CR30">30</xref>,
     <xref ref-type="bibr" rid="CR36">36</xref>,
     <xref ref-type="bibr" rid="CR58">58</xref>,
     <xref ref-type="bibr" rid="CR59">59</xref>,
     <xref ref-type="bibr" rid="CR69">69</xref>,
     <xref ref-type="bibr" rid="CR84">84</xref>,
    </td>
   </tr>
   <tr>
    <td>MAPT (17q21.31)</td>
    <td>Microtubule-associated protein Tau</td>
    <td>Modulates the stability of axonal microtubules</td>
    <td>RF</td>
    <td>Haplotype H1/H2</td>
    <td>
     <xref ref-type="bibr" rid="CR25">25</xref>
    </td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>N/A indicates mutations not studied in iPSC-PD studies.</p>
  <p>
   <italic>AD</italic> autosomal dominant; 
   <italic>AR</italic> autosomal recessive; 
   <italic>RF</italic> risk factor; 
   <italic>del</italic> deletion.
  </p>
 </table-wrap-foot>
</table-wrap>
